Forms


PROJECT REGISTRATION AND AMENDMENTS

Institutional Biosafety Committee (IBC) members review projects; non-exempt projects are sent to the full IBC for review, comment, and approval.
The project submittal deadline is 5 pm on the first Wednesday of each month. [IBC Meeting schedules]
Summary of the NIH Guidelines will assist you in determining which category/categories your experiments fall under. 


Type of Work

Form

All experiments involving the use of recombinant DNA (rDNA)

Acrobat Recombinant DNA   Word Word       

Experiments involving:

 a) BSL-2 or BSL-3 human, animal, or plant pathogens.
 b) Unknown human and animal pathogens.
 c) Primary human tumor cells.
 d) Cell lines immortalized with a virus (e.g. EBV, SV40, retrovirus)
 e) Human blood, body fluids, or tissues known to be positive for human
    disease-causing agents

Acrobat Biological Agent   Word Word      

Any work with biological toxins with a mammalian LD50 ≤ 100 µg/kg body weight

Acrobat Acute Toxin   Word Word

Addition or deletion of project personnel or project location; termination of project

Acrobat Administrative Amendment   Word Word 

Addition of a host, target recipient,  gene insert, or methodology to existing rDNA registration

Acrobat Technical Change Amendment*   Word Word

Addition of a non-viral vector to existing rDNA registration

Acrobat Technical Change Amendment*   Word Word

Acrobat rDNA Section 6   Word Word

Addition of a viral vector to existing rDNA registration

Acrobat Technical Change Amendment*   Word Word

Acrobat rDNA Section 6   Word Word

Acrobat rDNA Section 7   Word Word

Addition of a biological agent, host, or methodology to existing BA registration

Acrobat Technical Change Amendment*   Word Word

Acrobat Biological Agent Section 5 Word Word

Addition of a toxin, host, or methodology to existing AT registration

Acrobat Technical Change Amendment*   Word Word

Acrobat Acute Toxin Section 2   Word Word     

 

Acrobat Continuation Space (above forms)  Word Word

*The new use of rDNA in animals or new use of agents which fall under a different section of the NIH Guidelines for Research Involving Recombinant DNA Molecules than the original project approval will need to be reviewed and approved by the Institutional Biosafety Committee (IBC).


BIOPATH FORMS

BioPath:

Biohazards Medical Monitoring Program

Acrobat Authorization Form

Acrobat Medical Assessment Questionnaire

Acrobat BioPath Renewal Form


 

BLOODBORNE PATHOGENS

 

2012 Bloodborne Pathogen Program and
Biomedical Waste Training Compliance

Acrobat Receipt of BBP Materials  and Training Coordinator Designation Form   Word Word

Acrobat List of Individuals Trained   Word Word

Acrobat Acceptance/Declination of HBV Vaccination  (Training & Vaccination Form)   Word Word

Acrobat Standard Operating Procedures   Word Word 


 

ANIMAL CONTACT

Animal Contact Medical Monitoring Program

Acrobat Risk Assessment for Animal Contact   Word Word

Acrobat Renewal Risk Assessment for Animal Contact   Word Word